On Jan 11, 2022 PostEra closed a Series A round and raised $24,000,000 from ACE & Company, Breyer Capital, Clermont Group, HOF Capital, I2BF Global […]
Series A – ProVerum Medical
On Jan 11, 2022 ProVerum Medical closed a Series A round and raised €30,000,000 from Atlantic Bridge University Fund, Gilde Healthcare, Lightstone Ventures, featuring lead […]
Series A – Cardo Health
On Jan 11, 2022 Cardo Health closed a Series A round and raised $17,500,000 from investors, featuring lead investors . About the company: Cardo Health […]
Series A – AvengeBio
On Jan 5, 2022 AvengeBio closed a Series A round and raised $45,000,000 from CAM Capital, Longitude Capital, Pappas Capital, Perceptive Advisors, Rock Springs Capital, […]
Series B – Korro Bio
On Jan 5, 2022 Korro Bio closed a Series B round and raised $116,000,000 from Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset […]
Series B – SalioGen Therapeutics
On Jan 5, 2022 SalioGen Therapeutics closed a Series B round and raised $115,000,000 from Cystic Fibrosis Foundation, D1 Capital Partners, EPIQ Capital Group, Fidelity […]
Series A – Headversity
On Jan 5, 2022 Headversity closed a Series A round and raised CA$12,500,000 from Birchcliff Partners LP, Level Equity Management, Westcap, featuring lead investors Level […]
Series A – AvengeBio
On Jan 5, 2022 AvengeBio closed a Series A round and raised $45,000,000 from CAM Capital, Longitude Capital, Pappas Capital, Perceptive Advisors, Rock Springs Capital, […]
Series A – VLP Therapeutics
On Dec 27, 2021 VLP Therapeutics closed a Series A round and raised $21,000,000 from Miyako Capital, MUFG Bank, Nobelpharma, Robert Hisaoka, SK Impact Fund, […]
Series A – VLP Therapeutics
On Dec 27, 2021 VLP Therapeutics closed a Series A round and raised $21,000,000 from Miyako Capital, MUFG Bank, Nobelpharma, Robert Hisaoka, SK Impact Fund, […]
